# Meiweida Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/meiweida-medical

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Latest round: Series A (Dec 2, 2025)
- Investors on record: 3

## About

Based in Shanghai, China and founded in 2017, Shanghai Meiweida Medical Technology Co., Ltd., trading as Meiweida Medical is a medical device developer focusing on interventional oncology treatment. In December 2025, Meiweida Medical raised a series A+ funding led by new investor ChuangVest Ventures, with participation from new investors Yueli Capital, and Ysun Investment.

Currently, the company's innovative coaxial puncture thermocoagulation needle has successfully entered Shanghai's Class II medical device innovation channel, and its approved microwave ablation products have been included in Shanghai's list of new and superior drugs and medical devices. In addition, several other products independently developed by the company are in the registration application process, covering areas such as interventional oncology treatment and intraoperative real-time navigation.

The company's revenue is generated by selling innovative disposable coaxial puncture thermocoagulation needle and other medical devices.

The company will use the latest funding for new product development, clinical trials of innovative medical devices, and clinical promotion.

## Funding rounds

- Series A, Dec 2, 2025 — Ysun Investment, ChuangVest Ventures, Yueli Capital

## Investors

- Ysun Investment (https://capitalatlas.ai/funds/ysun-investment) — Series A
- ChuangVest Ventures (https://capitalatlas.ai/funds/chuangvest-ventures) — Series A
- Yueli Capital (https://capitalatlas.ai/funds/yueli-capital) — Series A